
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1189033
[patent_doc_number] => 06734169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders'
[patent_app_type] => B2
[patent_app_number] => 09/865989
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 45636
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 560
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734169.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865989 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | May 24, 2001 | Issued |
Array
(
[id] => 1189033
[patent_doc_number] => 06734169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders'
[patent_app_type] => B2
[patent_app_number] => 09/865989
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 45636
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 560
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734169.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865989 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | May 24, 2001 | Issued |
Array
(
[id] => 1270628
[patent_doc_number] => 06653281
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Ring modified cyclic peptide analogs'
[patent_app_type] => B1
[patent_app_number] => 09/763114
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16961
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653281.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763114
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763114 | Ring modified cyclic peptide analogs | May 23, 2001 | Issued |
Array
(
[id] => 715853
[patent_doc_number] => 07053057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Caspase inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/863649
[patent_app_country] => US
[patent_app_date] => 2001-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18809
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053057.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863649
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863649 | Caspase inhibitors and uses thereof | May 22, 2001 | Issued |
Array
(
[id] => 7092365
[patent_doc_number] => 20010033827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Inhibition of mucin release from airway goblet cells by polycationic peptides'
[patent_app_type] => new
[patent_app_number] => 09/858542
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5847
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20010033827.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858542 | Inhibition of mucin release from airway goblet cells by polycationic peptides | May 16, 2001 | Abandoned |
Array
(
[id] => 938491
[patent_doc_number] => 06972320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-06
[patent_title] => 'Ligation method and reagents to form an amide bond'
[patent_app_type] => utility
[patent_app_number] => 10/276515
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14847
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/972/06972320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276515 | Ligation method and reagents to form an amide bond | May 10, 2001 | Issued |
Array
(
[id] => 6880445
[patent_doc_number] => 20010031732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'New histidine derivatives, preparation process, and their use as free antiradical agents'
[patent_app_type] => new
[patent_app_number] => 09/852741
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5801
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031732.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852741 | Histidine derivatives, preparation process, and their use as free antiradical agents | May 10, 2001 | Issued |
Array
(
[id] => 6880445
[patent_doc_number] => 20010031732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'New histidine derivatives, preparation process, and their use as free antiradical agents'
[patent_app_type] => new
[patent_app_number] => 09/852741
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5801
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031732.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852741 | Histidine derivatives, preparation process, and their use as free antiradical agents | May 10, 2001 | Issued |
Array
(
[id] => 1300213
[patent_doc_number] => 06624142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-23
[patent_title] => 'Trimethyl lock based tetrapartate prodrugs'
[patent_app_type] => B2
[patent_app_number] => 09/852335
[patent_app_country] => US
[patent_app_date] => 2001-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11302
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/624/06624142.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852335
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852335 | Trimethyl lock based tetrapartate prodrugs | May 8, 2001 | Issued |
Array
(
[id] => 1303400
[patent_doc_number] => 06620781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-16
[patent_title] => 'Glycopeptide carboxy-saccharide derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/847052
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18601
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/620/06620781.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847052
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847052 | Glycopeptide carboxy-saccharide derivatives | Apr 30, 2001 | Issued |
Array
(
[id] => 6476660
[patent_doc_number] => 20020022590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Glycopeptide phosphonate derivatives'
[patent_app_type] => new
[patent_app_number] => 09/847042
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23258
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847042
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847042 | Glycopeptide phosphonate derivatives | Apr 30, 2001 | Issued |
Array
(
[id] => 6621948
[patent_doc_number] => 20020065221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Control of protein synthesis, and screening method for agents'
[patent_app_type] => new
[patent_app_number] => 09/845667
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19020
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065221.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845667
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845667 | Control of protein synthesis, and screening method for agents | Apr 29, 2001 | Abandoned |
Array
(
[id] => 6623431
[patent_doc_number] => 20020016288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells'
[patent_app_type] => new
[patent_app_number] => 09/842104
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 38139
[patent_no_of_claims] => 137
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016288.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842104
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842104 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells | Apr 29, 2001 | Abandoned |
Array
(
[id] => 5802543
[patent_doc_number] => 20020010315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/842543
[patent_app_country] => US
[patent_app_date] => 2001-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10161
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010315.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842543
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842543 | Peptoid and nonpeptoid containing -keto oxadiazoles as serine protease inhibitors | Apr 25, 2001 | Issued |
Array
(
[id] => 6660387
[patent_doc_number] => 20030135031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Purification of polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/258191
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12347
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20030135031.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258191 | Purification of polypeptides | Apr 19, 2001 | Issued |
Array
(
[id] => 741460
[patent_doc_number] => 07030089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-18
[patent_title] => 'Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione'
[patent_app_type] => utility
[patent_app_number] => 10/258620
[patent_app_country] => US
[patent_app_date] => 2001-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3798
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258620 | Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione | Apr 18, 2001 | Issued |
Array
(
[id] => 782817
[patent_doc_number] => 06992065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-31
[patent_title] => 'Sustained release formulations'
[patent_app_type] => utility
[patent_app_number] => 09/839684
[patent_app_country] => US
[patent_app_date] => 2001-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 2428
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/992/06992065.pdf
[firstpage_image] =>[orig_patent_app_number] => 09839684
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/839684 | Sustained release formulations | Apr 18, 2001 | Issued |
Array
(
[id] => 6438464
[patent_doc_number] => 20020128171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Methods for prevention and treatment of gastrointestinal disorders'
[patent_app_type] => new
[patent_app_number] => 09/840014
[patent_app_country] => US
[patent_app_date] => 2001-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29750
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128171.pdf
[firstpage_image] =>[orig_patent_app_number] => 09840014
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/840014 | Methods for prevention and treatment of gastrointestinal disorders | Apr 18, 2001 | Issued |
Array
(
[id] => 5936566
[patent_doc_number] => 20020061839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Serine peptidase modulators'
[patent_app_type] => new
[patent_app_number] => 09/837537
[patent_app_country] => US
[patent_app_date] => 2001-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17281
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09837537
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/837537 | Serine peptidase modulators | Apr 17, 2001 | Abandoned |
Array
(
[id] => 6885096
[patent_doc_number] => 20010039260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Pulmonary insulin crystals'
[patent_app_type] => new
[patent_app_number] => 09/836496
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3220
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039260.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836496
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836496 | Pulmonary insulin crystals | Apr 16, 2001 | Abandoned |